関連する実験動画
Updated: May 6, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.7K
基礎動脈閉塞と軽度の欠乏症の患者で,メカニカルトロンベクトミーで治療した結果の予測:多センターの遡及的観察研究
Simone Bellavia1, Andrea M Alexandre2, Luca Scarcia3
1Catholic University School of Medicine, Rome Italy; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
まとめ
メカニカル・トロンベクトミー (MT) は,軽度の症状を持つ基礎動脈閉塞 (BAO) 患者にとって有益である可能性があります. 上の小脳動脈の向こうの遠端閉塞は,MT後により良い結果を予測します.
科学分野:
- 神経学 神経学とは
- 介入神経学の介入神経学
- ストローク医学は,脳卒中医学である.
背景:
- 軽度の症状 (NIHSS<10) の基礎動脈閉塞 (BAO) のメカニカル・トロンベクトミー (MT) の利点は十分に調査されていない.
- 欧州のガイドラインは,軽度のBAOの最良の医療管理 (BMM) を提案しているが,証拠は矛盾している.
- MTは,選択された軽度のBAO患者で有益である可能性があります.
研究 の 目的:
- MTで治療された軽度の症状を有するBAO患者における神経学的結果に影響を与える処置前および処置後の要因を調査する.
- 軽度のBAOのMT後の好ましい機能的結果の予測要因を特定する.
主な方法:
- 欧州の脳卒中センター10カ所 (2017年1月~2024年12月) で行われた遡及的観察研究.
- NIHSS<10と事前改変ランキンスケール (mRS) <3.3の連続したBAO患者を含む.
- 3ヶ月のmRS 0-2および0-3の評価結果;NIHSS <6.6に対する感度分析.
主要な成果:
- 148人のBAO患者 (NIHSS<10) が確認され,128人がMTを受けた.
- MT治療を受けた133人の患者のうち,69.9%がmRS 0-2を達成し,75.9%がmRS 0-3を達成しました.
- 遠端閉塞 (上脳小動脈を超えて) は独立して好ましい結果 (mRS 0-2と0-3) を予測した.
結論:
- 軽度の症状のBAO患者における遠隔閉塞は,MTを患っている患者では,3ヶ月後の良好な機能的結果の強力な予測因子です.
- 閉塞部位は,軽度のBAOのMTにおける患者選択において極めて重要です.
関連する概念動画
Mitral Regurgitation III: Medical Management
691
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests
565
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
565
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762

